scholarly journals Thrombolytic Action of Apixaban on Intra-Atrial Thrombus Developed after Previous Treatment with Warfarin: A Case Report

2016 ◽  
Vol 25 (5) ◽  
pp. 491-493 ◽  
Author(s):  
Ernesto Valero ◽  
Enrique Santas ◽  
Julio Núñez
2019 ◽  
Vol 11 (6) ◽  
Author(s):  
Raymond Pranata ◽  
Emir Yonas ◽  
Veresa Chintya ◽  
Alexander Edo Tondas ◽  
Sunu Budhi Raharjo

2018 ◽  
Vol 2 (2) ◽  
Author(s):  
Jean-Benoît le Polain de Waroux ◽  
Christophe Scavée ◽  
Sébastien Marchandise

2016 ◽  
Vol 9 (1) ◽  
Author(s):  
Sahela Nasrin ◽  
Fathima Aaysha Cader ◽  
Md. Salahuddin ◽  
Tahera Nazrin ◽  
Masuma Jannat Shafi

2020 ◽  
pp. 030089162097698
Author(s):  
Emma Zattarin ◽  
Francesca Ligorio ◽  
Federico Nichetti ◽  
Giulia Bianchi ◽  
Giuseppe Capri ◽  
...  

Introduction: Breast cancer in men is less common than in women and treatment recommendations are often derived from clinical trials exclusively involving women. Data on efficacy of CDK 4/6 inhibitors, which are the mainstay of treatment for hormone receptor–positive/HER2-negative advanced breast cancer, are lacking in male patients. Case report: We present a clinical case of prolonged benefit from palbociclib in combination with letrozole and LHRH analogue in a man who had previously been treated with six lines of endocrine therapies and chemotherapy regimens but was still in excellent clinical condition. Conclusions: This clinical case demonstrates that male breast cancer stands out as an endocrine-sensitive disease, which could potentially benefit from CDK 4/6 inhibitors in combination with endocrine agents even in very heavily pretreated settings of disease, underscoring both the importance of an accurate selection of patients for later treatment lines, taking into account disease history and previous treatment responses, and the peculiarity of breast cancer in men, which deserves dedicated clinical trials to tailor future recommendations.


2014 ◽  
Vol 30 (10) ◽  
pp. 739-743 ◽  
Author(s):  
NW Shammas ◽  
R Padaria ◽  
G Ahuja

Objective Right atrial thrombus in the setting of a large pulmonary embolus is rare and is associated with serious adverse events. This case report presents the role played by EKOS EkoSonic ultrasound system in successfully treating right atrial thrombus and massive pulmonary embolism. Case report A 69-year-old female presented with a massive pulmonary embolus and a large mobile right atrial thrombus. She was treated with catheter-directed lysis using the EKOS EkoSonic ultrasound system and tissue plasminogen activator, with complete resolution of her right atrial thrombus and a marked improvement in her pulmonary embolus and hemodynamics. Conclusion This case report provides a new and an effective option to treat right atrial thrombus associated with a large pulmonary embolus leading to a good outcome.


1975 ◽  
Vol 3 (1) ◽  
pp. 65-67 ◽  
Author(s):  
H. W. Poehlmann ◽  
L. L. Basta ◽  
R. E. Brown

Sign in / Sign up

Export Citation Format

Share Document